<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1A884C9-7D4C-4683-A7F9-0529D770F4CD"><gtr:id>E1A884C9-7D4C-4683-A7F9-0529D770F4CD</gtr:id><gtr:name>Opal Oncology Limited</gtr:name><gtr:address><gtr:line1>23 SCIENCE PARK</gtr:line1><gtr:city>CAMBRIDGE</gtr:city><gtr:postCode>CB4 0EY</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1A884C9-7D4C-4683-A7F9-0529D770F4CD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>E1A884C9-7D4C-4683-A7F9-0529D770F4CD</gtr:id><gtr:name>Opal Oncology Limited</gtr:name><gtr:address><gtr:line1>23 SCIENCE PARK</gtr:line1><gtr:city>CAMBRIDGE</gtr:city><gtr:postCode>CB4 0EY</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>150000.0</gtr:offerGrant><gtr:projectCost>200286.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1E3EC6AF-3C75-469F-ADD0-969C99C7856B" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>1E3EC6AF-3C75-469F-ADD0-969C99C7856B</gtr:id><gtr:name>Piramal Imaging Limited</gtr:name><gtr:address><gtr:line1>LANGSTONE TECHNOLOGY PARK LANGSTONE ROAD , HAVANT</gtr:line1><gtr:city>HAMPSHIRE</gtr:city><gtr:postCode>PO9 1SA</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>0.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8EB39105-59F6-4565-839C-28EF43E2FDF1"><gtr:id>8EB39105-59F6-4565-839C-28EF43E2FDF1</gtr:id><gtr:firstName>Andy</gtr:firstName><gtr:surname>Morley</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131007"><gtr:id>C589AAD7-ACAB-48EB-A551-6EFF40ACB1CD</gtr:id><gtr:title>IKKb Inhibitor Proposal</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131007</gtr:grantReference><gtr:abstractText>IKKb inhibition is an interesting approach to tackle a number of diseases where there is currently signifcant unmet medical needs. Opal Oncology is using creative approaches to design, prepare and evaluate novel compounds with attractive biological, physicochemical, pharmacokinetic and safety profiles. Preferred compounds will subsequently be progressed into in vivo disease model evaluation alongside GLP toxicity and safety pharmacology evaluation as a precursor to candidate selection and help prioritise clinical evaluation plans to select appropriate disease indications.</gtr:abstractText><gtr:fund><gtr:end>2013-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2012-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>150000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131007</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>